Current Ratio of ImmunityBio, Inc. from 30 Jun 2016 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
ImmunityBio, Inc. quarterly Current Ratio in x history and change rate from 30 Jun 2016 to 31 Dec 2025.
- ImmunityBio, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 4.4x, a 30% increase year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
ImmunityBio, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 4.4x | +1x | +30% | 31 Dec 2025 |
| Q3 2025 | 3.92x | +0.11x | +3% | 30 Sep 2025 |
| Q2 2025 | 3.08x | -0.5x | -14% | 30 Jun 2025 |
| Q1 2025 | 3.08x | +2.13x | +226% | 31 Mar 2025 |
| Q4 2024 | 3.39x | +2.87x | +553% | 31 Dec 2024 |
| Q3 2024 | 3.81x | +3.51x | +1158% | 30 Sep 2024 |
| Q2 2024 | 3.58x | +3.32x | +1252% | 30 Jun 2024 |
| Q1 2024 | 0.95x | +0.61x | +179% | 31 Mar 2024 |
| Q4 2023 | 0.52x | +0.06x | +13% | 31 Dec 2023 |
| Q3 2023 | 0.3x | -0.37x | -55% | 30 Sep 2023 |
| Q2 2023 | 0.27x | -0.37x | -58% | 30 Jun 2023 |
| Q1 2023 | 0.34x | -0.51x | -60% | 31 Mar 2023 |
| Q4 2022 | 0.46x | -0.63x | -58% | 31 Dec 2022 |
| Q3 2022 | 0.67x | -0.78x | -54% | 30 Sep 2022 |
| Q2 2022 | 0.63x | -1.11x | -64% | 30 Jun 2022 |
| Q1 2022 | 0.85x | -1.44x | -63% | 31 Mar 2022 |
| Q4 2021 | 1.09x | -1.98x | -65% | 31 Dec 2021 |
| Q3 2021 | 1.46x | -2.41x | -62% | 30 Sep 2021 |
| Q2 2021 | 1.74x | -2.19x | -56% | 30 Jun 2021 |
| Q1 2021 | 2.29x | -1.52x | -40% | 31 Mar 2021 |
| Q4 2020 | 3.07x | -0.91x | -23% | 31 Dec 2020 |
| Q3 2020 | 3.87x | -0.65x | -14% | 30 Sep 2020 |
| Q2 2020 | 3.93x | -0.06x | -1.5% | 30 Jun 2020 |
| Q1 2020 | 3.81x | -0.1x | -2.6% | 31 Mar 2020 |
| Q4 2019 | 3.99x | -0.39x | -9% | 31 Dec 2019 |
| Q3 2019 | 4.52x | -0.66x | -13% | 30 Sep 2019 |
| Q2 2019 | 3.99x | -1.92x | -32% | 30 Jun 2019 |
| Q1 2019 | 3.91x | -1.74x | -31% | 31 Mar 2019 |
| Q4 2018 | 4.38x | -2.24x | -34% | 31 Dec 2018 |
| Q3 2018 | 5.17x | -2.84x | -35% | 30 Sep 2018 |
| Q2 2018 | 5.9x | -4.89x | -45% | 30 Jun 2018 |
| Q1 2018 | 5.65x | -12.07x | -68% | 31 Mar 2018 |
| Q4 2017 | 6.63x | -14.59x | -69% | 31 Dec 2017 |
| Q3 2017 | 8.01x | -19.86x | -71% | 30 Sep 2017 |
| Q2 2017 | 10.79x | -25.04x | -70% | 30 Jun 2017 |
| Q1 2017 | 17.72x | 31 Mar 2017 | ||
| Q4 2016 | 21.21x | 31 Dec 2016 | ||
| Q3 2016 | 27.87x | 30 Sep 2016 | ||
| Q2 2016 | 35.83x | 30 Jun 2016 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.